Alijagic A, Orešič M, Hyötyläinen T. Perfluorohexyloctane: More than Meets the Eye? Chem Res Toxicol. 2026 Feb 16;39(2):205-207. doi: 10.1021/acs.chemrestox.5c00507. Epub 2026 Feb 2. PMID: 41628141; PMCID: PMC12914703.
Alijagic A, Chaker J, Barbosa JMG, Duberg D, Castro-Alves V, Dickens AM, Orešič M, Hyötyläinen T. Metabolic effects and biotransformation of perfluorohexyloctane in human hepatocytes. Environ Int. 2026 Feb;208:110112. doi: 10.1016/j.envint.2026.110112. Epub 2026 Jan 29. PMID: 41628539.
You Song, Xueqi Fan, Maria T. Hultman, Maria Christou, Jan Thomas Rundberget, Camden K. Klefbom, Yan Lin, Yangzhao Sun, Jun Huang, and Li Xie. Next Generation Risk Assessment of Emerging PFOA Alternatives Using Integrated New Approach Methodologies. Environmental Science & Technology. 2025 Nov 21; https://doi.org/10.1021/acs.est.5c11122. Epub ahead of print.
Nguyen AH, Castro-Alves V, Holmström Flores E, Barbosa JMG, Kråkström M, Reinivuori P, Kauko O, Dickens A, Orešič M, Hyötyläinen T. The SIMPLIFY Protocol: A Monophasic Extraction System Suitable for Exposomics, Metabolomics, Lipidomics, and Proteomics Research. Anal Chem. 2025 Dec 2;97(47):26175-26183. doi: 10.1021/acs.analchem.5c05322. Epub 2025 Nov 19. PMID: 41258906; PMCID: PMC12676512.
Dileo E, Saba F, Parasiliti-Caprino M, Rosso C, Bugianesi E. Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies. Nutrients. 2025;17(3):477. doi:10.3390/nu17030477.
Andi Alijagic, Lisanna Sinisalu, Daniel Duberg, Oleksandr Kotlyar, Nikolai Scherbak, Magnus Engwall, Matej Orešič, Tuulia Hyötyläinen. Metabolic and phenotypic changes induced by PFAS exposure in two human hepatocyte cell models. Environment International. 2024 Aug 17; 190190:108820. doi.org/10.1016/j.envint.2024.108820. Epub ahead of print. PMID: 38906088.
